Search - tctmd.com

Displaying 801 - 820 of 3285

Sort: Relevancy | Date

Presentation TVT 2022

Acurate Neo2: Update From the ACURATE IDE and Related Studies

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Deep Shock and Severe AS With Prohibitive Femoral Access Conundrum: Solution and Outcome

Presenter: Bhavith Aruni

June 08, 2022

Presentation TVT 2022

Portico Navitor: Early US Clinical Experience and Update From the Portico NG (Navitor) Study

Presenter: Azeem Latib

June 08, 2022

Presentation TVT 2022

Impella-Assisted Rapid PercAx PCI and TAVR

Presenter: Michael Cryer

June 08, 2022

Presentation TVT 2022

A look forward: evidence gaps and prospective research needs to change the clinical practice of AR treatment

Presenter: Mark Russo

June 08, 2022

Presentation TVT 2022

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Presenter: John K. Forrest

June 08, 2022

Presentation TVT 2022

The Future of Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Presenter: Tamim M. Nazif

June 08, 2022

Presentation TVT 2022

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Presenter: Ravi Ramana

June 08, 2022

Presentation TVT 2022

Last Remaining Myocyte: Emergency ECMO and Staged PCI + TAVR

Presenter: Joseph Walsh

June 08, 2022

Presentation TVT 2022

Current and Future Standards for THV and Delivery System Platforms

Presenter: Rahul Sharma

June 08, 2022

Presentation TVT 2022

Patient Selection, Technical Considerations, and Clinical Outcomes

Presenter: Anita W. Asgar

June 08, 2022

Presentation TVT 2022

Total "Tandem" Approach for Cardiogenic Shock: TAVR and PCI

Presenter: Geoffrey Kunz

June 08, 2022

Presentation TVT 2022

Pushing the threshold: comparing aortic regurgitation outcomes to current guidelines and the possible need for earlier intervention

Presenter: Saif Anwaruddin

June 08, 2022

Presentation TVT 2022

The undertreatment of aortic regurgitation and understanding the need for surgical alternatives

Presenter: Vinod Thourani

June 08, 2022

Presentation TVT 2022

AR Home Run/Home Tomorrow

Presenter: Pratik Dalal

June 08, 2022

Presentation TVT 2022

Shared Decision-making: How Should the Heart Team Approach PMR Patients in the Gray Zone of Risk and Anatomy?

Presenter: Megan Coylewright

June 08, 2022

Presentation TVT 2022

Patient Selection Is the Key! Defining the Green and Yellow "Light Zones" for Mitral TEER: Are They Immutable?

Presenter: D. Scott Lim

June 08, 2022

Presentation TVT 2022

Cardiogenic Shock With Flash TAVR: The Importance of Event Sequencing

Presenter: Mark Bieniarz

June 08, 2022

Presentation TVT 2022

Clinician Expectations: Implications of Residual MR Post Mitral Valve Repair – Surgery vs TEER

Presenter: Allan Schwartz

June 08, 2022

Presentation TVT 2022

The Topaz TTVR System

Presenter: Geraldine Ong

June 08, 2022

Advertisement

Acurate Neo2: Update From the ACURATE IDE and Related Studies

Deep Shock and Severe AS With Prohibitive Femoral Access Conundrum: Solution and Outcome

Portico Navitor: Early US Clinical Experience and Update From the Portico NG (Navitor) Study

Impella-Assisted Rapid PercAx PCI and TAVR

A look forward: evidence gaps and prospective research needs to change the clinical practice of AR treatment

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

The Future of Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Last Remaining Myocyte: Emergency ECMO and Staged PCI + TAVR

Current and Future Standards for THV and Delivery System Platforms

Patient Selection, Technical Considerations, and Clinical Outcomes

Total "Tandem" Approach for Cardiogenic Shock: TAVR and PCI

Pushing the threshold: comparing aortic regurgitation outcomes to current guidelines and the possible need for earlier intervention

The undertreatment of aortic regurgitation and understanding the need for surgical alternatives

AR Home Run/Home Tomorrow

Shared Decision-making: How Should the Heart Team Approach PMR Patients in the Gray Zone of Risk and Anatomy?

Patient Selection Is the Key! Defining the Green and Yellow "Light Zones" for Mitral TEER: Are They Immutable?

Cardiogenic Shock With Flash TAVR: The Importance of Event Sequencing

Clinician Expectations: Implications of Residual MR Post Mitral Valve Repair – Surgery vs TEER

The Topaz TTVR System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content